Log In
BCIQ
Print this Print this
 

INCB53914

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
DescriptionPan-PIM kinase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationHematologic malignancies
Indication DetailsTreat advanced hematologic malignancies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today